Antiretroviral resistance is not an important risk of the oral tenofovir prophylaxis trial in Botswana: a simple mathematical modeling approach Dawn K.
Michael Roche PhD Student Burnet Institute
HealthWatch Africa
HIV Resistance Testing Clinical Implications Cyril K. Goshima, M.D. Director, AIDS Education Project June, 2009.
ARV Drug Resistance
DNA for Dummies (and the intellectually astute) A Dr. Parrott Production.
